Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability
Auteurs : Hélène Zéphir, Raphaël Bernard-Valnet, Christine Lebrun, Olivier Outteryck, Bertrand Audoin, Bertrand Bourre, Sophie Pittion, et al.
sfsep.org
Société Francophone de la Sclérose En Plaques
